| Stage | AXTI | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $48M | 100.00% | $96.2B | 100.00% | NVDA ×2021.92 |
| Gross profit | $21M | 44.90% | $72.1B | 74.98% | NVDA +30.1pp |
| Operating income | $10M | 21.90% | $63.7B | 66.24% | NVDA +44.3pp |
| Pre-tax income | $15M | 31.80% | $71.5B | 74.32% | NVDA +42.5pp |
| Net income | $13M | 27.38% | $59.7B | 62.03% | NVDA +34.7pp |
| Stage | AXTI | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $48M100.00% | $96.2B100.00% | NVDA ×2021.92 |
| Gross profit | 44.90%$21M | 74.98%$72.1B | NVDA +30.1pp |
| Operating income | 21.90%$10M | 66.24%$63.7B | NVDA +44.3pp |
| Pre-tax income | 31.80%$15M | 74.32%$71.5B | NVDA +42.5pp |
| Net income |
| 27.38%$13M |
| 62.03%$59.7B |
| NVDA +34.7pp |
None
No disclosed counterparties: AXTI.